nimodipine has been researched along with Retinal Diseases in 5 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Retinal Diseases: Diseases involving the RETINA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study we used two calcium antagonists which have two different modes of action, nimodipine and dantrolene, to prevent NMDA-induced retinal ischemia in guinea pigs." | 3.72 | Calcium antagonists in N-methyl d-aspartate-induced retinal injury. ( Altuntaş, I; Kaya, M; Ozdemir, T; Tunç, M, 2003) |
| "Nimodipine can inhibit the expression of VEGF at certain degrees." | 1.32 | [Experimental study of nimodipine and vascular endothelial growth factor in proliferative retinopathy]. ( Deng, DY; Han, LR; Kong, Y; Peng, YJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, CJ | 1 |
| Guo, Y | 1 |
| Agey, P | 1 |
| Wheeler, L | 1 |
| Hare, WA | 1 |
| Kaya, M | 1 |
| Tunç, M | 1 |
| Ozdemir, T | 1 |
| Altuntaş, I | 1 |
| Michalk, F | 1 |
| Michelson, G | 1 |
| Harazny, J | 1 |
| Werner, U | 1 |
| Daniel, WG | 1 |
| Werner, D | 1 |
| Kong, Y | 1 |
| Han, LR | 1 |
| Peng, YJ | 1 |
| Deng, DY | 1 |
| Fu, YH | 1 |
| Xu, J | 1 |
| Zhang, JS | 1 |
5 other studies available for nimodipine and Retinal Diseases
| Article | Year |
|---|---|
Nimodipine enhancement of alpha2 adrenergic modulation of NMDA receptor via a mechanism independent of Ca2+ channel blocking.
Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Calcium; Calcium Channel Blockers; Excitat | 2010 |
Calcium antagonists in N-methyl d-aspartate-induced retinal injury.
Topics: Animals; Calcium Channel Blockers; Cell Count; Dantrolene; Drug Therapy, Combination; Excitatory Ami | 2003 |
Single-dose nimodipine normalizes impaired retinal circulation in normal tension glaucoma.
Topics: Blood Circulation; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Female; Glaucoma, | 2004 |
[Experimental study of nimodipine and vascular endothelial growth factor in proliferative retinopathy].
Topics: Animals; Calcium Channel Blockers; Nimodipine; Rats; Rats, Sprague-Dawley; Retinal Diseases; Retinal | 2004 |
[Changes of expression of the P38 MAPK and caspase-3 in rat retinal ischemia-reperfusion model and the influence of Nimodipine].
Topics: Animals; Calcium Channel Blockers; Caspase 3; Female; Male; Nimodipine; p38 Mitogen-Activated Protei | 2006 |